NO20005725L - Biologisk aktiv sammensetning - Google Patents

Biologisk aktiv sammensetning

Info

Publication number
NO20005725L
NO20005725L NO20005725A NO20005725A NO20005725L NO 20005725 L NO20005725 L NO 20005725L NO 20005725 A NO20005725 A NO 20005725A NO 20005725 A NO20005725 A NO 20005725A NO 20005725 L NO20005725 L NO 20005725L
Authority
NO
Norway
Prior art keywords
biologically active
active agent
carrier
chemical operation
active composition
Prior art date
Application number
NO20005725A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005725D0 (no
Inventor
Aake Lindahl
Haakan Hagslaett
Catharina Benediktsson
Rickard Bryland
Original Assignee
Bioglan Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioglan Ab filed Critical Bioglan Ab
Publication of NO20005725D0 publication Critical patent/NO20005725D0/no
Publication of NO20005725L publication Critical patent/NO20005725L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20005725A 1998-05-14 2000-11-13 Biologisk aktiv sammensetning NO20005725L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801705A SE9801705D0 (sv) 1998-05-14 1998-05-14 Biologically active composition
PCT/SE1999/000824 WO1999058109A1 (en) 1998-05-14 1999-05-12 Biologically active composition

Publications (2)

Publication Number Publication Date
NO20005725D0 NO20005725D0 (no) 2000-11-13
NO20005725L true NO20005725L (no) 2001-01-11

Family

ID=20411319

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005725A NO20005725L (no) 1998-05-14 2000-11-13 Biologisk aktiv sammensetning

Country Status (20)

Country Link
EP (1) EP1077677B1 (ko)
JP (1) JP2002514588A (ko)
KR (1) KR100766998B1 (ko)
CN (1) CN1309554A (ko)
AT (1) ATE252371T1 (ko)
AU (1) AU742921B2 (ko)
CA (1) CA2332110A1 (ko)
DE (2) DE1077677T1 (ko)
DK (1) DK1077677T3 (ko)
ES (1) ES2155049T3 (ko)
GR (1) GR20010300014T1 (ko)
HU (1) HUP0102002A3 (ko)
IL (2) IL139577A0 (ko)
NO (1) NO20005725L (ko)
NZ (1) NZ508074A (ko)
PL (1) PL344221A1 (ko)
SE (1) SE9801705D0 (ko)
TR (1) TR200003588T2 (ko)
WO (1) WO1999058109A1 (ko)
ZA (1) ZA200006476B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003524652A (ja) * 2000-02-29 2003-08-19 ツァン,ツィエ 改良された経皮薬剤パッチ
EP1651192A1 (en) * 2003-08-06 2006-05-03 Nirmal Mulye Pharmaceutical composition containing water soluble drug
US8431140B2 (en) 2006-06-14 2013-04-30 Dr. Reddy's Laboratories, Inc. Topical compositions
WO2012028496A1 (de) * 2010-08-31 2012-03-08 Basf Se Verzweigte polyester auf basis von zitronensäure sowie deren herstellung und verwendung
EP2663285A2 (en) * 2011-01-13 2013-11-20 Qlt Inc. Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940701A (en) * 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
SE9502244D0 (sv) * 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
GB2306885B (en) * 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions

Also Published As

Publication number Publication date
EP1077677A1 (en) 2001-02-28
SE9801705D0 (sv) 1998-05-14
CA2332110A1 (en) 1999-11-18
JP2002514588A (ja) 2002-05-21
DE1077677T1 (de) 2001-09-20
GR20010300014T1 (en) 2001-04-30
AU4405199A (en) 1999-11-29
WO1999058109A1 (en) 1999-11-18
EP1077677B1 (en) 2003-10-22
AU742921B2 (en) 2002-01-17
DE69912271D1 (de) 2003-11-27
ZA200006476B (en) 2001-06-11
IL139577A0 (en) 2002-02-10
IL139577A (en) 2007-07-04
ATE252371T1 (de) 2003-11-15
NZ508074A (en) 2003-01-31
ES2155049T3 (es) 2004-05-16
PL344221A1 (en) 2001-10-08
KR100766998B1 (ko) 2007-10-15
TR200003588T2 (tr) 2001-06-21
CN1309554A (zh) 2001-08-22
NO20005725D0 (no) 2000-11-13
DK1077677T3 (da) 2004-02-16
HUP0102002A2 (hu) 2002-03-28
DE69912271T2 (de) 2004-08-26
ES2155049T1 (es) 2001-05-01
HUP0102002A3 (en) 2002-12-28
KR20010052349A (ko) 2001-06-25

Similar Documents

Publication Publication Date Title
Pommier et al. The formation and resealing of intercalator-induced DNA strand breaks in isolated L1210 cell nuclei
ES2118677T3 (es) Una composicion que comprende un agente activo disuelto en un vehiculo formador de vidrio y un procedimiento para su preparacion.
CL2010001333A1 (es) Metodo para cristalizar en estado solido particulas esfericas de una mezcla de dos o mas compuestos organicos alotropicos, obtenidas por fusion-pulverizacion y congelamiento, que incluye someter a dichas particulas a una atmosfera que contiene vapores de solvente (divisional de sol. 213-99).
SE8105897L (sv) Sett for mikroinkapsling
DE50004352D1 (de) Farbmittelzubereitungen
PT1133284E (pt) Um processo para a preparacao de particulas cristalinas
CO5070580A1 (es) Formulacion farmaceutica para aerosoles con dos o mas sustancias activas
ES2143131T3 (es) Proceso para eliminacion de colorantes.
NO970610L (no) Sammensetning for selektiv frigjöring av en aktiv ingrediens
NO20005725L (no) Biologisk aktiv sammensetning
ATE310500T1 (de) Biologisch aktive zusammensetzung
US5994407A (en) Procedure to prepare a solution with capsaicin
TR199901044T2 (en) Endos�lfan-mikrokaps�l da��l�m�.
Bownds et al. In vitro physiology of frog photoreceptor membranes
KR910000540A (ko) 물을 처리하는 방법
ATE68345T1 (de) Pharmazeutische zubereitung zur cholelitholyse.
McLafferty Early Shannon mass spectrometry
Vaughan Effects of choleragen and fluoride on adenylate cyclase
KR0130540B1 (en) Repellent composition containing porous alumina silica
KR960029252A (ko) 수처리제 조성물
KR910002493A (ko) 다공질화산암(多孔質火山岩)을 활용한 공해방지제 (公害防止劑)의 제조방법
MD1112F1 (ro) Procedeu de obţinere a reagentului pentru determinarea concentraţiei minime inhibatoare a antibioticelor
EP0667153A4 (en) PROCESS FOR THE PREPARATION OF A COMPOSITION FOR A SOLID MEDICAMENT.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application